Hemanext Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

Hemanext General Information

Description

Developer of transfusion medical technology designed to support the transfusion medicine community in efforts to save lives and improve patient outcomes. The company offers novel storage methods to potentially extend the shelf life of refrigerated red blood cells while enhancing the quality across the storage cycle, enabling healthcare providers to promote improvements in the quality, safety, and efficacy, and reduce the cost of transfusion therapy.

Contact Information

Website
hemanext.com
Formerly Known As
New Health Systems, New Health Sciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 99 Hayden Avenue, Building B
  • Suite 620
  • Lexington, MA 02421
  • United States
+1 (781)
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 99 Hayden Avenue, Building B
  • Suite 620
  • Lexington, MA 02421
  • United States
+1 (781)

Hemanext Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemanext Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
23. Secondary Transaction - Private 01-Feb-2026 Completed Generating Revenue
22. Later Stage VC (Series C) 04-Aug-2025 Completed Generating Revenue
21. Later Stage VC (Series B3) 22-Jul-2025 Completed Generating Revenue
20. Later Stage VC (Series B2) 01-Oct-2024 Completed Generating Revenue
19. Later Stage VC (Series B1) 05-Jan-2024 Completed Generating Revenue
18. Later Stage VC (Series C) 07-Feb-2023 Completed Generating Revenue
17. Later Stage VC (Series B) 07-Nov-2022 Completed Generating Revenue
16. Later Stage VC Completed Generating Revenue
15. Later Stage VC (Series A) 15-Oct-2021 $48.4M $82.8M Completed Generating Revenue
14. Debt - PPP 16-Apr-2020 $781K $34.4M Completed Clinical Trials - General
To view Hemanext’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hemanext Patents

Hemanext Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1084309-S1 Combination spacer and oxygen indicator for blood storage device Active 09-Dec-2022
US-D1084308-S1 Spacer for blood storage device Active 09-Dec-2022
EP-4604975-A1 Treatment of blood transfusion-dependent patients with hematologic malignancies Pending 20-Oct-2022
US-20260144821-A1 Treatment of blood transfusion-dependent patients with hematologic malignancies Pending 20-Oct-2022
WO-2024086835-A1 Treatment of blood transfusion-dependent patients with hematologic malignancies Inactive 20-Oct-2022 A61K35/14
To view Hemanext’s complete patent history, request access »

Hemanext Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hemanext Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Vitalant Corporation Minority
Antaeus Enterprises Family Office Minority
Eduardo Avayu Family Office Family Office Minority
Grabe Family Office Family Office Minority
Omega Advisors Hedge Fund Minority
You’re viewing 5 of 8 investors. Get the full list »

Hemanext FAQs

  • When was Hemanext founded?

    Hemanext was founded in 2000.

  • Where is Hemanext headquartered?

    Hemanext is headquartered in Lexington, MA.

  • What is the size of Hemanext?

    Hemanext has 52 total employees.

  • What industry is Hemanext in?

    Hemanext’s primary industry is Other Devices and Supplies.

  • Is Hemanext a private or public company?

    Hemanext is a Private company.

  • What is Hemanext’s current revenue?

    The current revenue for Hemanext is .

  • How much funding has Hemanext raised over time?

    Hemanext has raised $220M.

  • Who are Hemanext’s investors?

    Vitalant, Antaeus Enterprises, Eduardo Avayu Family Office, Grabe Family Office, and Omega Advisors are 5 of 8 investors who have invested in Hemanext.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process